Iterum Therapeutics Inc. (NASDAQ:ITRM) Stock Resumes Downtrend: Quarterly Earnings In Focus
Iterum Therapeutics Inc. (NASDAQ:ITRM) fell 7% on Friday after the company announced its Q3 2021 financial results for the quarter
Read more
ITRM
Iterum Therapeutics (NASDAQ:ITRM) Stock Takes a Hit: A Good Buy Opportunity?
Clinical-stage pharmaceutical company, Iterum Therapeutics (NASDAQ:ITRM), on July 26th, 2021 announced receiving Response Letter from the U.S. Food and Drug
Read more
Iterum Therapeutics plc (NASDAQ:ITRM) Stock Attempts To Recover From The Recent Slump
Iterum Therapeutics plc (NASDAQ:ITRM) ITRM jumped 9%, but it is down 40% in the past month. The company announced that
Read more
Iterum Therapeutics (NASDAQ:ITRM) stock Is Under Heavy Selling Pressure: Time To Sell?
The Iterum Therapeutics (NASDAQ:ITRM) stock continued to be in a slide yesterday and decline by 5.5% as the selloff in
Read more